Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).
暂无分享，去创建一个
T. Powles | N. Agarwal | M. Galsky | M. Milowsky | J. Rosenberg | J. Bellmunt | F. Recine | Y. Wong | A. Necchi | S. Crabb | E. Yu | L. Harshman | S. Pal | S. Ladoire | C. Théodore | U. Vaishampayan | S. Chowdhury | E. Moshier | D. Berthold | S. Hussain | Risc Investigators